Attached files
| file | filename |
|---|---|
| EX-32.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | v179145_ex32-1.htm |
| EX-32.2 - NAVIDEA BIOPHARMACEUTICALS, INC. | v179145_ex32-2.htm |
| EX-31.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | v179145_ex31-1.htm |
| EX-21.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | v179145_ex21-1.htm |
| EX-31.2 - NAVIDEA BIOPHARMACEUTICALS, INC. | v179145_ex31-2.htm |
| EX-24.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | v179145_ex24-1.htm |
| 10-K - NAVIDEA BIOPHARMACEUTICALS, INC. | v179145_10k.htm |
Exhibit
23.1
Consent
of Independent Registered Public Accounting Firm
Neoprobe
Corporation
Dublin,
Ohio
We hereby
consent to the incorporation by reference in the Registration Statements on Form
S-8 (Nos. 33-81410, 333-05143, 333-119219, 333-130636, 333-130640, 333-153110,
and 333-158323) of Neoprobe Corporation of our report dated March 29, 2010,
relating to the consolidated financial statements, which appears in this Form
10-K.
/s/ BDO
Seidman, LLP
Chicago,
Illinois
March 29,
2010